Enliven Therapeutics, Inc. · NASDAQ:ELVN
Enliven Therapeutics, Inc. shareholders
As of Jun 30, 2026, 203 institutions reported holding Enliven Therapeutics, Inc. Largest: Fidelity, Orbimed Advisors LLC and Polar Capital Holdings Plc. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Enliven Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 10M | +3.2M | Aug 13, 2026 | |
| Orbimed Advisors LLC | 6.78M | −1.18M | Aug 14, 2026 | |
| Polar Capital Holdings Plc | 6.43M | +1.36M | Aug 14, 2026 | |
| BlackRock | 4.36M | +675K | Aug 7, 2026 | |
| Vestal Point Capital, LP | 4M | +750K | Aug 14, 2026 | |
| Vanguard | 3.59M | +728K | Aug 13, 2026 | |
| Commodore Capital LP | 3.27M | no change | Aug 14, 2026 | |
| T. Rowe Price | 3.2M | +3.11M | Aug 14, 2026 | |
| Citadel | 2.07M | +325K | Aug 14, 2026 | |
| Fairmount Funds Management LLC | 1.86M | no change | Aug 14, 2026 |